(Q39426063)

English

Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical use.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical use. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

Elisa Giovannetti

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Adam E Frampton

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Tamara M H Gall

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Justin Stebbing

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Leandro Castellano

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Long R Jiao

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jonathan Krell

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

325-329

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate?

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

What we have learned about pancreatic cancer from mouse models.

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Towards a clinical use of miRNAs in pancreatic cancer biopsies

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration.

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

miRNA-708 control of CD44(+) prostate cancer-initiating cells

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2)

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

The rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic tool

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway.

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1586%2FERM.13.18

21 January 2018

Identifiers

10.1586/ERM.13.18

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39426063&oldid=1457305876"